Immunotoxicology: opportunities for non-animal test development

Area of Science:

• Toxicology
• Immunology
• In Vitro Methods

Background:

• Animal-based assays are standard for assessing chemical immunotoxicity, including immunosuppression and sensitization.
• These methods raise ethical concerns and have limitations in human risk assessment.
• Regulatory drivers, like the EU REACH system, promote the development of non-animal testing strategies.

Purpose of the Study:

• To review the current state of in vitro immunotoxicity testing.
• To identify the need for advanced non-animal methods for chemical safety assessment.
• To highlight the importance of developing assays for hypersensitivity, immunosuppression, immunostimulation, and autoimmunity.

Main Methods:

• Review of existing literature and regulatory landscapes in immunotoxicology.
• Analysis of the limitations of current animal-based assays.
• Identification of the need for novel cell-based in vitro assays.

Main Results:

• Significant advancements in in vitro toxicology are driven by regulatory changes and ethical considerations.
• Existing in vitro methods are insufficient for comprehensive immunotoxicity assessment.
• A gap exists in simple, fast, economical, and reliable cell-based assays for predicting xenobiotic effects on the immune system.

Conclusions:

• In vitro immunotoxicity assays are essential for the future of chemical safety testing.
• There is a critical need for the development of new cell-based assays to address current limitations.
• These assays must be reliable, efficient, and cost-effective for regulatory acceptance and human safety protection.